New drug candidate STF 1623 activates innate immunity in solid tumors

Cancer immunotherapy, which primes the body’s immune system to fight off tumors, has historically focused on…

Beshear Bans Designer Xanax Drug in Kentucky as AGs Urge Emergency Action

Kentucky Gov. Andy Beshear took emergency action Monday to ban the sale of “designer Xanax,” responding…

Recognizing Innovation in Drug Delivery: Dr. Hagar Labouta Wins 2025 Rising Women in Science Award

Dr. Hagar Labouta, Assistant Professor at the University of Manitoba and a valued member of the…

Swiss Re Tackles Longevity Drug Impact With Life Policy Advice

Swiss Re AG issued guidance for underwriters on how to assess life insurance applications of people…

The Uncertain Future of Medicare’s Stand-Alone Prescription Drug Plan Market and Why It Matters

Ahead of Medicare’s annual mid-year announcement about the national average premium for Part D prescription drug…

Insilico Medicine begins clinical trial for AI-designed cancer drug ISM3412

Insilico Medicine(“Insilico”), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announces that the…

AI-designed drug shows early promise for lung fibrosis patients in clinical trial

A groundbreaking phase 2a study reveals that rentosertib, an AI-developed TNIK inhibitor, could offer new hope…

Affordable HIV drug shows promise in improving vision for diabetic eye disease

An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes…

Reducing Polypharmacy Through Innovative Drug Formulation

In this interview, NewsMedical speaks with Joanna Lipner, Co-Founder of PIKRALIDA, and Hanna Kierońska, Head of Drug…